{ }
001122334455554433221100
001122334455554433221100

Insilico Medicine secures 110 million dollars in series E funding round

Insilico Medicine, an AI-driven drug discovery company, has raised $110 million in its Series E funding round, achieving a valuation of over $1 billion. The investment, led by Value Partners Group, will enhance its AI platform and support the clinical development of Rentosertib for idiopathic pulmonary fibrosis, which has completed Phase IIa trials.With a pipeline of 30 drug assets, including 10 approved by the US FDA for investigational use, Insilico also licenses its assets to firms like Fosun Pharma and Exelixis, securing contracts worth approximately $3.5 billion. The company is advancing its proprietary AI system, “pharma.ai,” and developing humanoid robots to automate lab processes.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.